TY - JOUR
T1 - Surgical do's and don'ts of corneal dystrophies
AU - Lee, Eun Suk
AU - Kim, Eung Kweon
PY - 2003/8
Y1 - 2003/8
N2 - Purpose of review: Characteristics of corneal dystrophies have been described with regards to such as location in the cornea, morphology, material composition, and recurrence after penetrating keratoplasty. The main goal of this review is to describe the surgical methods in treating corneal dystrophies. Recent findings: Laser in situ keratomileusis (LASIK) has been shown to aggravate corneal deposits in Avellino dystrophy exacerbation LASIK and hence should be avoided. Phototherapeutic keratectomy (PTK) has shown its usefulness in clearing opacities with visual improvement and prevents painful erosion, resulting in delay or postponement of corneal grafting in some corneal dystrophies. Mitomycin-C may be used topically in conjunction with PTK to reduce the recurrence of the opacities. Topical use of antibody to TGF-β can also be considered to suppress recurrence of corneal opacities after PTK or lamellar keratectomy. Summary: Clinicians must become more adept at choosing a treatment depending on different genotypes and future studies on treatment of corneal dystrophies should be focused on establishing treatment of categorized corneal dystrophies based on their chromosomal mutation.
AB - Purpose of review: Characteristics of corneal dystrophies have been described with regards to such as location in the cornea, morphology, material composition, and recurrence after penetrating keratoplasty. The main goal of this review is to describe the surgical methods in treating corneal dystrophies. Recent findings: Laser in situ keratomileusis (LASIK) has been shown to aggravate corneal deposits in Avellino dystrophy exacerbation LASIK and hence should be avoided. Phototherapeutic keratectomy (PTK) has shown its usefulness in clearing opacities with visual improvement and prevents painful erosion, resulting in delay or postponement of corneal grafting in some corneal dystrophies. Mitomycin-C may be used topically in conjunction with PTK to reduce the recurrence of the opacities. Topical use of antibody to TGF-β can also be considered to suppress recurrence of corneal opacities after PTK or lamellar keratectomy. Summary: Clinicians must become more adept at choosing a treatment depending on different genotypes and future studies on treatment of corneal dystrophies should be focused on establishing treatment of categorized corneal dystrophies based on their chromosomal mutation.
UR - http://www.scopus.com/inward/record.url?scp=0042443418&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042443418&partnerID=8YFLogxK
U2 - 10.1097/00055735-200308000-00003
DO - 10.1097/00055735-200308000-00003
M3 - Review article
C2 - 12888715
AN - SCOPUS:0042443418
SN - 1040-8738
VL - 14
SP - 186
EP - 191
JO - Current Opinion in Ophthalmology
JF - Current Opinion in Ophthalmology
IS - 4
ER -